Antiretroviral News and Research

RSS

Scientists say valproic acid can eradicate dormant HIV

Early research by scientists in the U.S. suggests that valproic acid could be a potential way to eradicate dormant HIV infections.

14 Aug 2005

New therapeutic approach that could help eliminate dormant HIV infection

US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week’s issue of The Lancet.

11 Aug 2005

HAART reduces AIDS rates by 86%

Highly active antiretroviral therapy (HAART) for HIV-infected individuals has reduced the rate of progression to AIDS or death by 86%, according to new research from Bristol University published in The Lancet.

2 Aug 2005

People with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries

It also shows that people with HIV who are given free ART drugs will do "significantly" better at fighting the disease compared to those who must pay for the drugs.

1 Aug 2005

Combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission

Two new studies support the hypothesis that combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission through breastfeeding, findings that could have significant implications in the developing world.

29 Jul 2005

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.

15 Jul 2005

Police shooting of AIDS protesters by South African police

AIDS Healthcare Foundation (AHF) today expressed its profound outrage over the unprovoked attack -- including what is believed to be the first-ever police shooting of AIDS protesters anywhere worldwide -- by South African police on AIDS activists conducting a peaceful protest.

15 Jul 2005

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

Johns Hopkins infectious disease specialists who have spent more than two decades leading efforts to combat HIV and AIDS worldwide are warning that limited international relief supplies of antiretroviral therapies currently being distributed in Africa, Asia and the Caribbean will not get to those who can least afford to pay for them.

28 Jun 2005

WHO says AIDS fight will only be won with generic drugs

According to the World Health Organisation (WHO) the key to AIDS treatment in the developing world is generic drugs, but the target of 3 million people on therapy by the end of 2005 may now be unattainable.

21 Jun 2005

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Researchers from the Johns Hopkins Bloomberg School of Public Health, Centers for Disease Control and Prevention and the Chiang Mai University in Thailand, evaluated the ability of inexpensive biological markers, which are obtainable in resource-poor countries, to determine which HIV-infected patients are in the greatest need of antiretroviral therapy.

20 Jun 2005

Dental care needs for HIV patients continue to rise

People with HIV now are living longer and the number of dental patients treated monthly at the Oregon Health & Science University School of Dentistry's Russell Street Clinic continues to grow.

16 Jun 2005

Tentative approval for Lamivudine tablets

The U.S. Food and Drug Administration (FDA) has announced the tentative approval of Lamivudine Tablets manufactured by Aurobindo Pharma LTD. Hyderabad, India.

16 Jun 2005

Risky sexual behaviour fuelled in gay and bisexual men by the internet

A U.S. study says that gay and bisexual men who use the internet to meet partners are apparently more likely to engage in risky sex but tend to do so with people who have the same HIV status.

16 Jun 2005

Promising new tuberculosis drug enters clinical trial

A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced this week.

15 Jun 2005

Trade agreements 'bad medicine' for AIDS, says AIDS Healthcare Foundation

AIDS advocates from AIDS Healthcare Foundation (AHF), the nation's largest provider of HIV/AIDS medical care serving thousands of patients in the U.S., Africa, Central America and Asia, today hailed Representative Henry Waxman (D-CA) for his release of a new report detailing how the pending Central American Free Trade Agreement (CAFTA) and other trade agreements like NAFTA derail access to affordable generic medications in Latin and Central America and other developing world countries, including access to life-saving anti-retroviral therapies (ARVs) for HIV/AIDS treatment.

10 Jun 2005

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.

9 Jun 2005

UN warns of the losing battle in world AIDS fight

UN officials are saying that their goal of containing the AIDS pandemic by 2015 may now be unrealistic because the spread of the disease is outpacing the efforts of many countries to prevent it.

5 Jun 2005

Progress on HIV/AIDS significant but insufficient

United Nations Secretary-General Kofi Annan today shared his hope with a gathering of senior world officials at Headquarters that the 2001 Declaration of Commitment on HIV/AIDS would have heralded a response that matched the epidemic’s scale, yet progress had been “significant but insufficient”.

3 Jun 2005

HIV/AIDS drugs may also be effective against malaria

Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.

2 Jun 2005

HIV deaths drop 90 percent among African-American IDUs who are given access to combination drug therapy

Combination drug therapy effectively reduces 90 percent of HIV deaths in African-American injection drug users when they are given ample access to care, according to a new Academy study in the June issue of the American Journal of Epidemiology.

1 Jun 2005